Can Rollins (ROL) Stock Reach $38?

Rollins, Inc. (ROL) is one of the world's largest pest-control providers, best known for its Orkin brand, with a business built on recurring residential and commercial service contracts. After a steep slide from a 52-week high of roughly $66 in February 2026, the stock trades near its 52-week low, and investors are asking whether a recovery toward a $38 stock price target is realistic. That figure represents the average of current, credible analyst price targets rather than a single firm's forecast, and it implies a substantial move from current levels.

Key Takeaways

• The central target of $38 is the arithmetic mean of current analyst price targets reviewed for this analysis, not an official published consensus.
• With the stock around $32.66, reaching $38 would require a move of roughly 16%, a substantial advance from today's depressed levels.
• Current targets span a wide range—roughly $32 to $49—reflecting genuine disagreement about the pace of a growth rebound.
• Recurring revenue, the Orkin brand, and an active acquisition pipeline are the strongest supporting factors.
• Slowing organic growth, margin pressure, and an FTC enforcement action on noncompete clauses are the biggest obstacles.

Analyst Price Targets and Consensus View

Wall Street has been aggressively marking down its expectations for Rollins in 2026. In July, firms including Bank of America (to Underperform), Wells Fargo (to Underweight), and J.P. Morgan (to Hold) issued downgrades, while RBC Capital moved to Sector Perform and Bernstein to Market Perform. By October, individual targets clustered much lower: Citi set a $32 target, UBS moved to $36, J.P. Morgan to $35, Bernstein to $35, and Bank of America to $35, while more constructive names held higher marks—Morgan Stanley at $43, Barclays at $45, and Goldman Sachs at $49.

After excluding clearly stale targets from the spring (when the stock traded above $50, including figures of $66 and $72 that have since been revised lower), roughly 11 current targets remain, ranging from about $32 to $49. Their average is approximately $38, the central target used here. The dispersion is unusually wide: cautious analysts see limited near-term upside, while bulls argue the market is over-discounting temporary headwinds. This is not a confident, uniform analyst consensus—it is a divided one.

Current Market Position and Path Toward the Target

Rollins closed near $32.66 on October 19, 2026, down more than 50% from its February peak and just above its 52-week low of $29.29. A move to $38 would mean a gain of roughly 16%, a substantial recovery that would still leave the shares well below their prior highs. The stock trades at roughly 29 times trailing earnings (P/E), with a dividend yield near 2.2%.

The path to $38 likely depends on evidence that organic growth is stabilizing. Management has cited weather-related disruption as a near-term drag on growth, a factor several analysts describe as transitory. A durable rebound in residential and commercial pest-control demand, combined with accretive acquisitions, could restore confidence in the premium valuation Rollins has historically commanded.

What Could Support a Move Toward the Target

• Recurring revenue model: Rollins' contract-based services provide predictable, sticky cash flows that historically support a premium multiple.
• Brand strength: Orkin remains a market leader in North America with strong awareness and route density advantages.
• Acquisitions: Management has invested roughly $900 million over three years in tuck-in deals, targeting a couple of percentage points of annual growth from M&A.
• Valuation reset: After the decline, some analysts argue the shares no longer price in the company's long-term growth potential.

What Could Prevent the Target From Being Reached

• Slowing organic growth: Recent quarters have shown weaker expansion than analysts had modeled, prompting repeated estimate cuts.
• Margin pressure: Several firms expect results to miss on profitability even if revenue holds up.
• Regulatory risk: The FTC ordered Rollins to stop enforcing noncompete agreements for more than 18,000 workers, which could raise labor costs and turnover.
• Valuation compression: Even after the fall, a near-30x P/E leaves little room for error if growth disappoints.

Technical Levels and Market Structure

Rollins is trading below both its 50-day (about $33.92) and 200-day (about $48) moving averages, confirming a downtrend in place for much of 2026. The 52-week low near $29.29 acts as a key support level, while the recent $34–$35 zone and the 50-day average represent initial resistance. Any sustained recovery toward $38 would first need to reclaim these nearer levels, a task complicated by heavy selling pressure seen over the summer and fall.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms apply different assumptions about growth, margins, and the appropriate multiple. The most immediate catalyst is Rollins' third-quarter earnings report, expected around October 21, 2026, where investors will scrutinize organic growth, margins, and any commentary on acquisition activity and the FTC's noncompete action. Subsequent analyst revisions—particularly any stabilization of the target-cutting trend—will also be important to watch.

AI Daily Buy/Sell Signals

Traders seeking a more timely, data-driven view can turn to Tickeron's AI Daily Buy/Sell Signals. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. By surfacing shifts in trend and momentum automatically, it helps traders discover opportunities, monitor existing positions, and spot changing market structure more efficiently than manual review alone. Explore the signals to see how this tool can complement your own research.

Final Assessment

Whether Rollins can reach $38 depends on whether the company can demonstrate that its recent growth slowdown is temporary rather than structural. The central target, an average of roughly 11 current analyst targets ranging from about $32 to $49, implies a 16% recovery from the $32.66 price—substantial but not unrealistic given the stock's own recent history. Supportive factors include a resilient recurring-revenue model, the Orkin brand, and an active acquisition strategy, while slowing organic growth, margin pressure, valuation risk, and the FTC action represent meaningful obstacles. The wide spread between bullish and bearish targets shows that even professional analysts disagree sharply. The upcoming earnings report and subsequent estimate revisions are the key data points to monitor before drawing any conclusion.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations